- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Global Brand Lead , Neuroscience is responsible for driving the creation and execution of the early commercial strategy for our company's emerging ... forecasts for in-flight and emerging discovery programs.The Director, Global Brand Lead is focused on developing a future-focused view of company's Neuroscience… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …and more efficiently.About the PositionWe are seeking a seasoned Staff Engineer to lead our AI Foundations Team-a new initiative dedicated to establishing the ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …bring new treatments to patients faster and more efficiently.Responsibilities Lead the design, development, and deployment of software solutions that leverage AI ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Lundbeck (New York, NY)
- …advance brain health and transform lives. Join us on our journey of growth !BioPharmaceutical Regional Business Director - East Will consider candidates who live in ... KY.SUMMARY:The Regional Business Director (RBD) is responsible for leading field-based Area Sales Managers (ASM) and Biopharmaceutical Account Managers (BAM) to… more
- Merck & Co. (Rahway, NJ)
- …to achieve optimal results with limited day-to-day direction from Therapeutic Area Lead .Strong verbal and written communication skills Preferred Experience: ... (Principal Scientist), Global Regulatory Affairs Liaison with a visionary, growth -oriented mindset that can help advance our pipeline and...where the compound is first-in-class or is in a new therapeutic area for our company; where… more
- Merck & Co. (Rahway, NJ)
- …strategic initiatives across our company as well as the establishment of new strategies, and capabilities. This role will work cross-functionally with senior leaders ... Associate Vice President, Head of Commercial Strategy Development.Located in Rahway, New Jersey preferred, candidates from Upper Gwynedd, Pennsylvania, will be… more
- CBRE (New York, NY)
- …as a change agent for business improvements and develops buy-in and support for new initiatives and processes. *Effectively manage and lead team through change. ... Property Management Market Leader Job ID 191831 Posted 21-Feb-2025 Service line...Role type Full-time Areas of Interest Property Management Location(s) New York City - New York -… more
- Microsoft Corporation (New York, NY)
- …There is a different range applicable to specific work locations, within the San Francisco Bay area and New York City metropolitan area , and the base pay ... Join the Retail & Consumer Goods Organization as a **Global Strategic Sales Leader ** with our Microsoft Pepsico Team. In this role, you will oversee the development… more
- Stantec (New York, NY)
- …a long-term view of the industry, market, and client base. + Assist in the growth of ES by establishing new service areas. + Anticipate medium- and long-term ... Environmental Services - Sector Leader , Transmission & Distribution - ( 250000A9 )...**Description** Grounded in safety, quality, and ethics, our experts lead their fields and guide our work with rigor,… more
